Our Terms of Service and Privacy Policy have changed.

By continuing to use this site, you are agreeing to the new Privacy Policy and Terms of Service.

Valeant Pharmaceuticals International Inc (NYSE:VRX)

12.48
Delayed Data
As of 4:00pm ET
 +0.09 / +0.73%
Today’s Change
8.31
Today|||52-Week Range
24.30
-14.05%
Year-to-Date

Today’s Trading

Previous close12.39
Today’s open12.14
Day’s range11.89 - 12.59
Volume19,618,246
Average volume (3 months)14,736,077
Market cap$4.3B
Dividend yield--
Data as of 4:00pm ET, 10/19/2017

Growth & Valuation

Earnings growth (last year)-716.47%
Earnings growth (this year)-32.70%
Earnings growth (next 5 years)-2.95%
Revenue growth (last year)-7.39%
P/E ratioNM
Price/Sales0.52
Price/Book1.37

Competitors

 Today’s
change
Today’s
% change
GLPGGalapagos NV-1.47-1.45%
CTLTCatalent Inc+0.51+1.21%
ACADACADIA Pharmaceutica...-0.90-2.45%
TAROTaro Pharmaceutical ...+2.32+2.20%
Data as of 4:02pm ET, 10/19/2017

Financials

Next reporting dateNovember 7, 2017
EPS forecast (this quarter)$0.90
Annual revenue (last year)$9.7B
Annual profit (last year)-$2.4B
Net profit margin-24.90%

Profile

Sector
Health Technology
Industry
Pharmaceuticals: Other
Chairman &
Chief Executive Officer
Joseph C. Papa
Chief Financial Officer &
Executive VP-Finance
Paul S. Herendeen
Corporate headquarters
Laval, Quă©bec

Forecasts